Pacific Biosciences of California, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $1.82
- 52-Week Range
- $1.07 – $3.44
- Market Cap
- $571.39M
- P/E (TTM)
- —
- EPS (TTM)
- -0.42
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- —
- PEG Ratio
- —
- Return on Equity
- —
- Return on Assets
- -44.07%
- Gross Margin
- 27.67%
- Operating Margin
- -332.99%
- Profit Margin
- -81.31%
- Current Ratio
- 4.62
- Debt/Equity
- —
- Total Debt
- $708.37M
- Free Cash Flow
- $44.06M
- Revenue Growth
- 5.50%
- Earnings Growth
- —
- Enterprise Value
- $1.08B
Market Snapshot
About
Pacific Biosciences develops and manufactures sequencing systems for genetic analysis, specializing in long-read sequencing technology. The company produces the Sequel and Revio systems, which can read much longer DNA fragments than traditional short-read sequencing, enabling better genome assembly and detection of structural variants. Its technology is used in research, clinical diagnostics, and agricultural genomics.